IMUX FY 2019 Earnings — Immunic, Inc. Revenue & Financial Results | Market Cap Arena

IMUXImmunic, Inc.

$138M

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$50,000

Operating Income

-$37M

Net Income

-$35M

EPS (Diluted)

$-4.51

Cash Flow

Operating Cash Flow

-$29M

Free Cash Flow

-$29M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$66M

Total Liabilities

$8M

Stockholders' Equity

$58M

Cash & Equivalents

$29M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$50,000	-$15,000	-233.3%
Operating Income	-$37M	-$42M	+11.9%
Net Income	-$35M	-$41M	+16.0%